Vorasidenibe é aprovado pela ANVISA para o tratamento do glioma difuso grau 2 do tipo adulto com mutação IDH1/IDH2.⁸

Biografia

Oncologia Brasil is a specialized oncology platform with a team of experts covering all aspects of cancer treatment, providing relevant content and personalized solutions. Its goal is to meet the needs of healthcare professionals, pharmaceutical industries, and patients by offering reliable and up-to-date information to improve cancer understanding and management.